{"id":7157,"date":"2025-04-28T11:16:11","date_gmt":"2025-04-28T09:16:11","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/us\/?post_type=publication&p=7157"},"modified":"2025-04-28T21:05:37","modified_gmt":"2025-04-28T19:05:37","slug":"the-concomitant-of-non-classical-stereotactic-body-radiotherapy-with-tislelizumab-based-on-multidisciplinary-modalities-for-leiomyosarcoma-a-case-report","status":"publish","type":"publication","link":"https:\/\/beonemedaffairs.com\/us\/publication\/the-concomitant-of-non-classical-stereotactic-body-radiotherapy-with-tislelizumab-based-on-multidisciplinary-modalities-for-leiomyosarcoma-a-case-report\/","title":{"rendered":"The concomitant of non-classical stereotactic body radiotherapy with tislelizumab based on multidisciplinary modalities for leiomyosarcoma: A case report"},"content":{"rendered":"","protected":false},"template":"","post-tag":[],"class_list":["post-7157","publication","type-publication","status-publish","hentry","disease_state-leiomyosarcoma","molecule-tislelizumab"],"acf":[],"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/publication\/7157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=7157"}],"wp:term":[{"taxonomy":"post-tag","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag?post=7157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}